[go: up one dir, main page]

AU7127000A - Enzyme inhibitors - Google Patents

Enzyme inhibitors

Info

Publication number
AU7127000A
AU7127000A AU71270/00A AU7127000A AU7127000A AU 7127000 A AU7127000 A AU 7127000A AU 71270/00 A AU71270/00 A AU 71270/00A AU 7127000 A AU7127000 A AU 7127000A AU 7127000 A AU7127000 A AU 7127000A
Authority
AU
Australia
Prior art keywords
enzyme inhibitors
inhibitors
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71270/00A
Inventor
Timothy Bates
Renai Dianna Fossum
Garry Steven Garrett
Scott Edward Osborne
Todd Laurence Underiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU7127000A publication Critical patent/AU7127000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
  • Polyethers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
AU71270/00A 1999-09-10 2000-09-08 Enzyme inhibitors Abandoned AU7127000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15347399P 1999-09-10 1999-09-10
US60153473 1999-09-10
PCT/US2000/024713 WO2001018181A2 (en) 1999-09-10 2000-09-08 Enzyme inhibitors

Publications (1)

Publication Number Publication Date
AU7127000A true AU7127000A (en) 2001-04-10

Family

ID=22547365

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71270/00A Abandoned AU7127000A (en) 1999-09-10 2000-09-08 Enzyme inhibitors

Country Status (6)

Country Link
EP (1) EP1212098A2 (en)
JP (1) JP2003509538A (en)
AR (1) AR023272A1 (en)
AU (1) AU7127000A (en)
PE (1) PE20010588A1 (en)
WO (1) WO2001018181A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE476998T1 (en) * 1999-09-10 2010-08-15 Procter & Gamble POLYOXYALKYLENE CONJUGATES AS ENZYMIN HIBITORS
AU2002321536B2 (en) * 2001-08-30 2007-05-17 Norgine Bv Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
US8907154B2 (en) 2001-10-01 2014-12-09 The Procter & Gamble Company Sanitary napkins with hydrophobic lotions
US20030143186A1 (en) * 2001-11-13 2003-07-31 The Procter & Gamble Company Protease enzyme inhibitors
CN1620439A (en) * 2001-12-20 2005-05-25 Osi药物公司 Pancreatic lipase inhibitor compounds, their synthesis and use
US9035123B2 (en) 2002-10-01 2015-05-19 The Procter & Gamble Company Absorbent article having a lotioned topsheet
US20050048105A1 (en) * 2003-08-29 2005-03-03 Mcnulty Amy K. Protease inhibitor compositions for prevention and treatment of skin conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665070A (en) * 1985-06-25 1987-05-12 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use
DE4342154A1 (en) * 1993-12-10 1995-06-14 Behringwerke Ag Amidinophenylalanine derivatives, process for their preparation, their use and agents containing them as anticoagulants
US6267952B1 (en) * 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
ES2196790T3 (en) * 1998-03-12 2003-12-16 Procter & Gamble PROTEASE INHIBITORS IN ABSORBENT ARTICLES.
US6066673A (en) * 1998-03-12 2000-05-23 The Procter & Gamble Company Enzyme inhibitors
CN1300223A (en) * 1998-03-12 2001-06-20 宝洁公司 Disposable absorbent article having a skin care composition containing an enzyme inhibitor
WO2001017501A1 (en) * 1999-09-10 2001-03-15 The Procter & Gamble Company Enzyme inhibitors

Also Published As

Publication number Publication date
WO2001018181A2 (en) 2001-03-15
EP1212098A2 (en) 2002-06-12
PE20010588A1 (en) 2001-06-23
WO2001018181A3 (en) 2001-12-13
AR023272A1 (en) 2002-09-04
JP2003509538A (en) 2003-03-11

Similar Documents

Publication Publication Date Title
AU1878601A (en) Enzyme
IL138387A0 (en) Enzyme inhibitors
AU2001241078A1 (en) Alpha-amylase activity inhibitors
AU3074500A (en) Proteasome inhibitors
AU9059798A (en) Urokinase inhibitors
AU2576100A (en) Novel enzyme
AU7125700A (en) Enzyme inhibitors
GB9924522D0 (en) Enzyme inhibitors
AU3235100A (en) Prothease inhibitors
AU3761400A (en) Amino-thio-acrylonitriles as mek inhibitors
AU1588901A (en) Protease inhibitors
AU2849399A (en) Monobactam enzyme inhibitors
AU1474801A (en) Protease inhibitors
AU2373600A (en) Novel spla2 inhibitors
GB9816358D0 (en) Enzyme inhibitors
GB9906245D0 (en) Enzyme
AU7127000A (en) Enzyme inhibitors
AU3888200A (en) Protease inhibitors
AU4066900A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors
AU1474701A (en) Protease inhibitors
AU7127100A (en) Enzyme inhibitors
AUPQ180499A0 (en) Beta-amyloid peptide inhibitors
AU2001268853A1 (en) Biocatalyst inhibitors
AU7559600A (en) V type and/or x type spla2 inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase